Syncom Formulations (India) Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 529.37 million compared to INR 658.53 million a year ago. Revenue was INR 556.62 million compared to INR 671.67 million a year ago. Net income was INR 56.22 million compared to INR 92.35 million a year ago. Basic earnings per share from continuing operations was INR 0.06 compared to INR 0.12 a year ago. Diluted earnings per share from continuing operations was INR 0.06 compared to INR 0.12 a year ago. For the six months, sales was INR 1,042.06 million compared to INR 950.93 million a year ago. Revenue was INR 1,082.62 million compared to INR 973.06 million a year ago. Net income was INR 110.19 million compared to INR 122.01 million a year ago. Basic earnings per share from continuing operations was INR 0.14 compared to INR 0.16 a year ago. Diluted earnings per share from continuing operations was INR 0.13 compared to INR 0.16 a year ago.